Works about PIRENZEPINE

Results: 74

Olanzapin Kullanımı ile ilişkili Epileptik Nöbet: Olgu Sunumu.

Published in:

Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 3, p. 134

By:

Güleç, Gülcan;
Kılıç, Rukiye Yasemin

Publication type:

Article

Olanzapine Treatment in Choreoathetosis due to Bilateral Striopallidodentate Calcinosis.

Published in:

Klinik Psikofarmakoloji Bulteni, 2004, v. 14, n. 4, p. 209

By:

Balaban, Hatice;
Sahiner, Turker;
Degirmenci, Eylem

Publication type:

Article

Abuse of olanzapine by substance abusers.

Published in:

2007

By:

Reeves, Roy R.

Publication type:

journal article

Autoradiography of 3H-pirenzepine and 3H-AFDX-384 in Mouse Brain Regions: Possible Insights into M1, M2, and M4 Muscarinic Receptors Distribution.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00124

By:

Valuskova, Paulina;
Farar, Vladimir;
Forczek, Sandor;
Krizova, Iva;
Myslivecek, Jaromir

Publication type:

Article

Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake.

Published in:

2008

By:

Borella, T. L.;
De Luca Jr., L. A.;
Colombari, D. S. A.;
Menani, J. V.;
De Luca, L A Jr

Publication type:

journal article

Spinal α2-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.

Published in:

British Journal of Pharmacology, 2006, v. 148, n. 2, p. 233, doi. 10.1038/sj.bjp.0706731

By:

Takasu, Keiko;
Honda, Motoko;
Ono, Hideki;
Tanabe, Mitsuo

Publication type:

Article

Loss of M1 Receptor Dependent Cholinergic Excitation Contributes to mPFC Deactivation in Neuropathic Pain.

Published in:

Journal of Neuroscience, 2017, v. 37, n. 9, p. 2292, doi. 10.1523/JNEUROSCI.1553-16.2017

By:

Radzicki, Daniel;
Pollema-Mays, Sarah L.;
Sanz-Clemente, Antonio;
Martina, Marco

Publication type:

Article

Olanzapine induced neuroleptic malignant syndromea case review.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2003, v. 18, n. 4, p. 301, doi. 10.1002/hup.483

By:

Aleš Kogoj;
Ingrid Velikonja

Publication type:

Article

In vitro release of two anti-muscarinic drugs from soft contact lenses.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 1657, doi. 10.2147/OPTH.S141404

By:

Hui, Alex;
Bajgrowicz-Cieslak, Magdalena;
Chau-Minh Phan;
Jones, Lyndon

Publication type:

Article

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

Published in:

International Journal of General Medicine, 2012, v. 5, p. 391, doi. 10.2147/IJGM.S29052

By:

Ascher-Svanum, Haya;
Montgomery, William S.;
McDonnell, David P.;
Coleman, Kristina A.;
Feldman, Peter D.

Publication type:

Article

Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.

Published in:

Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 4, p. 364, doi. 10.1111/j.1440-1819.2004.01269.x

By:

CHAICHAN, WARAWAT

Publication type:

Article

De novo induction of obsessive–compulsive symptoms with quetiapine in a patient with borderline personality disorder.

Published in:

Australian & New Zealand Journal of Psychiatry, 2009, v. 43, n. 12, p. 1185, doi. 10.3109/00048670903279903

By:

Alexander, Jacob

Publication type:

Article

Characterization of fluoxetine plus olanzapine treatment in rats: A behavior, endocrine, and immediate-early gene expression analysis.

Published in:

Synapse, 2003, v. 50, n. 4, p. 353, doi. 10.1002/syn.10276

By:

Judith M. Horowitz;
Alpna Goyal;
Navindra Ramdeen;
Brian H. Hallas;
A. Thomas Horowitz;
German Torres

Publication type:

Article

Loss of Muscarinic Autoreceptor Function Impairs Long- Term Depression But Not Long-Term Potentiation in the Striatum.

Published in:

Journal of Neuroscience, 2008, v. 28, n. 24, p. 6258, doi. 10.1523/JNEUROSCI.1678-08.2008

By:

Bonsi, Paola;
Martella, Giuseppina;
Cuomo, Dario;
Platania, Paola;
Sciamanna, Giuseppe;
Bernardi, Giorgio;
Wess, Jürgen;
Pisani, Antonio

Publication type:

Article

The Effects on Place Cells of Local Scopolamine Dialysis Are Mimicked by a Mixture of Two Specific Muscarinic Antagonists.

Published in:

Journal of Neuroscience, 2004, v. 24, n. 42, p. 9313, doi. 10.1523/JNEUROSCI.1618-04.2004

By:

Brazhnik, Elena;
Borgnis, Ramie;
Muller, Robert U.;
Fox, Steven E.

Publication type:

Article

A Specific Synaptic Pathway Activates a Conditional Plateau Potential Underlying Protraction Phase in the Aplysia Feeding Central Pattern Generator.

Published in:

Journal of Neuroscience, 2004, v. 24, n. 22, p. 5230, doi. 10.1523/JNEUROSCI.5649-03.2004

By:

Dembrow, Nikolai C.;
Jing, Jian;
Brezina, Vladimir;
Weiss, Klaudiusz R.

Publication type:

Article

Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy.

Published in:

2017

By:

Calcutt, Nigel A.;
Smith, Darrell R.;
Frizzi, Katie;
Sabbir, Mohammad Golam;
Roy Chowdhury, Subir K.;
Mixcoatl-Zecuatl, Teresa;
Saleh, Ali;
Muttalib, Nabeel;
Van der Ploeg, Randy;
Ochoa, Joseline;
Gopaul, Allison;
Tessler, Lori;
Wess, Jürgen;
Jolivalt, Corinne G.;
Fernyhough, Paul;
Chowdhury, Subir K Roy

Publication type:

journal article

Synthesis of the olanzapine labeled by carbon-14.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 8, p. 325, doi. 10.1002/jlcr.3407

By:

Saadatjoo, Naghi;
Javaheri, Mohsen;
Saemian, Nader;
Amini, Mohsen

Publication type:

Article

Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution.

Published in:

Ophthalmic & Physiological Optics, 1999, v. 19, n. 4, p. 327, doi. 10.1016/S0275-5408(98)00079-9

By:

Cottriall, C. L.;
McBrien, N. A.;
Annies, R.;
Leech, E. M.

Publication type:

Article

CHARLES BONNET SYNDROME: VISUAL HALLUCINATION AND MULTIPLE SCLEROSIS.

Published in:

International Journal of Psychiatry in Medicine, 2003, v. 33, n. 2, p. 195, doi. 10.2190/0NUQ-Y5Q9-TA6H-RJHH

By:

Alao, Adekola O.;
Hanrahan, Brian

Publication type:

Article

Do Muscarinic Receptors Play a Role in Acute Pancreatitis?: A Randomised Comparison of Pirenzepine and Nasogastric Suction.

Published in:

Clinical Drug Investigation, 2000, v. 20, n. 6, p. 401, doi. 10.2165/00044011-200020060-00002

By:

Zapater, P.;
Abad-Santos, F.;
Alcalde-Rubio, M.;
Moreno-Otero, R.

Publication type:

Article

Pirenzepine gel slows myopia progression in children.

Published in:

Ocular Surgery News, 2008, v. 26, n. 21, p. 58

By:

Nale, Pat;
Gold, Robert S.

Publication type:

Article

Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland.

Published in:

Advances in Pharmacological Sciences, 2009, v. 2009, p. 1, doi. 10.1155/2009/787586

By:

Ryberg, Anders T.;
Soukup, Ondrej;
Tobin, Gunnar

Publication type:

Article

Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetes.

Published in:

2003

By:

Issa, Basil G.;
Davies, Nichola;
Hood, Kerenza;
Premawardhana, Lakdasa D.K.E.;
Peters, John R.;
Scanlon, Maurice F.

Publication type:

clinical trial

Pirenzepine Inhibits Myopia in Guinea Pig Model by Regulating the Balance of MMP-2 and TIMP-2 Expression and Increased Tyrosine Hydroxylase Levels.

Published in:

Cell Biochemistry & Biophysics, 2015, v. 71, n. 3, p. 1373, doi. 10.1007/s12013-014-0359-9

By:

Qian, Lifeng;
Zhao, Hong;
Li, Xiaoxia;
Yin, Juanjuan;
Tang, Wenjian;
Chen, Peng;
Wang, Qian;
Zhang, Jinsong

Publication type:

Article

Prejunctional Muscarinic Receptors Modulating Acetylcholine Release in Rabbit Detrusor Smooth Muscles.

Published in:

Urologia Internationalis, 1998, v. 61, n. 3, p. 135, doi. 10.1159/000030309

By:

Inadome, Akito;
Yoshida, Masaki;
Takahashi, Wataru;
Yono, Makoto;
Seshita, Hiroshi;
Miyamoto, Yutaka;
Kawano, Takashi;
Ueda, Shoichi

Publication type:

Article

Site-Directed Mutagenesis Implicates a Threonine Residue in TM6 in the Subtype Selectivities of UH-AH 37 and Pirenzepine at Muscarinic Receptors.

Published in:

Pharmacology, 2000, v. 61, n. 2, p. 62, doi. 10.1159/000028382

By:

Ellis, John;
Seidenberg, Margaret

Publication type:

Article

Animal Pharmacology of Reversible Antagonism of the Gastric Acid Pump, Compared to Standard Antisecretory Principles.

Published in:

Pharmacology, 2000, v. 60, n. 4, p. 179, doi. 10.1159/000028367

By:

Kromer, Wolfgang;
Postius, Stefan;
Riedel, Richard

Publication type:

Article

Effects of presynaptic muscarinic cholinoreceptor blockade on neuromuscular transmission as assessed by the train-of-four and the tetanic fade response to rocuronium.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 7, p. 795, doi. 10.1111/1440-1681.12763

By:

Kim, Yong Beom;
Lee, Sangseok;
Lee, Kyeong Chun;
Kim, Ha Jung;
Ro, Young Jin;
Yang, Hong‐Seuk

Publication type:

Article

Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.

Published in:

2001

By:

Tari, Akira;
Kuruhara, Yoshitada;
Yonei, Yoshikazu;
Yamauchi, Ryo;
Okahara, Shiro;
Sumii, Koji;
Kajiyama, Goro;
Tari, A;
Kuruhara, Y;
Yonei, Y;
Yamauchi, R;
Okahara, S;
Sumii, K;
Kajiyama, G

Publication type:

journal article

Does pirenzepine suppress the undesirable effects of a proton pump inhibitor on enterochromaffin-like cells?

Published in:

2001

By:

Shinomura, Yasuhisa;
Shinomura, Y

Publication type:

research

Effect of pirenzepine on gastric endocrine cell kinetics during lansoprazole administration.

Published in:

1998

By:

Omura, Nobuo;
Kashiwagi, Hideyuki;
Gang, Chen;
Omura, Kayoko;
Aoki, Teruaki;
Omura, N;
Kashiwagi, H;
Gang, C;
Omura, K;
Aoki, T

Publication type:

journal article

Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.

Published in:

Molecular Psychiatry, 2009, v. 14, n. 11, p. 1017, doi. 10.1038/mp.2008.28

By:

Scarr, E.;
Cowie, T. F.;
Kanellakis, S.;
Sundram, S.;
Pantelis, C.;
Dean, B.

Publication type:

Article

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.

Published in:

Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 869, doi. 10.2147/NDT.S59468

By:

Wenyu Ye;
Montgomery, William;
Kadziola, Zbigniew;
Li Liu;
Haibo Xue;
Stensland, Michael D.;
Treuer, Tamas

Publication type:

Article

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review.

Published in:

Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 841, doi. 10.2147/NDT.S58096

By:

Hai Bo Haber Xue;
Li Liu;
Hena Zhang;
Montgomery, William;
Treuer, Tamás

Publication type:

Article

Positive findings for negative symptoms of schizophrenia: no longer untreatable?

Published in:

2006

By:

Stahl, Stephen M.

Publication type:

Editorial

Atypical neuroleptic malignant syndrome caused by olanzapine.

Published in:

Acta Psychiatrica Scandinavica, 2005, v. 112, n. 3, p. 238, doi. 10.1111/j.1600-0447.2005.00578.x

By:

Nielsen, J.;
Bruhn, A. M.

Publication type:

Article

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.

Published in:

BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-20

By:

Katagiri, Hideaki;
Fujikoshi, Shinji;
Suzuki, Takuya;
Fujita, Kiyoshi;
Sugiyama, Naoya;
Takahashi, Michihiro;
Gomez, Juan-Carlos

Publication type:

Article

Effects of cholinesterase inhibition in supraspinal and spinal neural pathways on the micturition reflex in rats.

Published in:

BJU International, 2009, v. 104, n. 8, p. 1163, doi. 10.1111/j.1464-410X.2009.08515.x

By:

Masuda, Hitoshi;
Chancellor, Michel B.;
Kihara, Kazunori;
Sakai, Yasuyuki;
Koga, Fumitaka;
Azuma, Hiroshi;
de Groat, William C.;
Yoshimura, Naoki

Publication type:

Article

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study.

Published in:

Industrial Psychiatry Journal, 2014, v. 23, n. 1, p. 27, doi. 10.4103/0972-6748.144953

By:

Kumar, Subodh;
Chaudhury, Suprakash

Publication type:

Article

Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-ß-Cyclodextrin Inclusion Complex.

Published in:

Iranian Journal of Pharmaceutical Research, 2010, v. 9, n. 4, p. 335

By:

Shankarrao, Kulkarni Ajit;
Mahadeo, Ghadge Dhairysheel;
Balavantrao, Kokate Pankaj

Publication type:

Article

Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.

Published in:

Australasian Psychiatry, 2005, v. 13, n. 1, p. 72, doi. 10.1080/j.1440-1665.2004.02154.x

By:

Mondraty, Naresh;
Birmingham, C. Laird;
Touyz, Stephen;
Sundakov, Viktoria;
Chapman, Lucy;
Beumont, Pierre

Publication type:

Article

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.

Published in:

BMC Psychiatry, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12888-018-1867-8

By:

Men, Peng;
Yi, Zhanmiao;
Li, Chaoyun;
Qu, Shuli;
Xiong, Tengbin;
Yu, Xin;
Zhai, Suodi

Publication type:

Article

Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 1, p. 37, doi. 10.1017/S1461145712000028

By:

Gibbons, Andrew Stuart;
Scarr, Elizabeth;
Boer, Simone;
Money, Tammie;
Jeon, Won-Je;
Felder, Chris;
Dean, Brian

Publication type:

Article

L-Satropane Prevents Retinal Neuron Damage by Attenuating Cell Apoptosis and Aβ Production via Activation of M1 Muscarinic Acetylcholine Receptor.

Published in:

Current Eye Research, 2017, v. 42, n. 9, p. 1319, doi. 10.1080/02713683.2017.1315142

By:

Yu, Ping;
Zhou, Wei;
Liu, Lu;
Tang, Ya-Bin;
Song, Yun;
Lu, Juan-Juan;
Hou, Li-Na;
Chen, Hong-Zhuan;
Cui, Yong-Yao

Publication type:

Article

MUSCARINIC RECEPTOR SUBTYPES ARE CLEARLY DISCRIMINATED IN THE BRAIN BY MUSCARINIC TOXINS.

Published in:

1999

By:

Kornisiuk, E.;
Alfaro, P.;
Durán, R.;
Verde, E. Rial;
Cerveñansky, C.;
Jerusalinsky, D.

Publication type:

Abstract

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder.

Published in:

Patient Preference & Adherence, 2017, v. 11, p. 1019, doi. 10.2147/PPA.S124581

By:

Novick, Diego;
Montgomery, William;
Treuer, Tamas;
Ai Koyanagi;
Aguado, Jaume;
Kraemer, Susanne;
Haro, Josep Maria

Publication type:

Article

Characterization of pirenzepine interaction with cytochrome P-450

Published in:

Xenobiotica, 1985, v. 15, n. 5, p. 399, doi. 10.3109/00498258509045010

By:

Rendic, S.;
Ruf, H.-H.

Publication type:

Article

Colonic Inflammation Increases the Contribution of Muscarinic M2 Receptors to Carbachol-Induced Contraction of the Rat Colon.

Published in:

Medical Principles & Practice, 2011, v. 20, n. 6, p. 530, doi. 10.1159/000328419

By:

Jragh, Dina M.;
Khan, Islam;
Oriowo, Mabayoje A.

Publication type:

Article

Age-Related Peculiarities of Inotropic Response of Rat Myocardium to Selective Block of M1-Cholinoreceptors.

Published in:

Bulletin of Experimental Biology & Medicine, 2013, v. 155, n. 6, p. 708, doi. 10.1007/s10517-013-2232-z

By:

Zefirov, T.;
Ziyatdinova, N.;
Zefirov, A.

Publication type:

Article